Medicines – Open House rebate agreements 2026-25 for follitropin alfa

Summary

The tender concerns rebate agreements for medicines containing the active substance follitropin alfa. It is an Open House procedure by TK, under which contracts are concluded with all suitable pharmaceutical companies on uniform terms, without individual negotiations. The contracts are non-exclusive and run for a maximum of 24 months from 01/08/2026, but no later than 31/07/2028. The exact participation and contract conditions must be checked in the tender documents.